Biomaterials are substances that are natural or synthetic, living or lifeless and made up of multiple components that interact with biological systems. These biological materials are used in implants or medical device which performs, enhances or replace any natural bodily functions. Implantable biomaterials are engineered to take up form of any body function. As body does not accept completely any foreign material to augment its biological functions, implantable biomaterials are designed in a way to reduce the negative immune response given by body while maintaining adequate function. Implantable biomaterials find several applications in medical surgery, dental problems and effectively used in several critical disorders like cardiovascular diseases, tissue damage etc. Implantable biomaterial also are used in as an allograft or xenograft in transplant surgery. Implantable Biomaterials are of significant importance as they have been proven to be reliable, safe and feasible. Implantable biomaterials are used in drug delivery systems as controlled drug release system. Implantable biomaterial are used as biodegradable polymeric carriers. Implantable biomaterials are also porous bio ceramics utilized in various matrices to deliver drugs and other biologically active agents. Implantable biomaterial are made up of several types of substances including metals, ceramics and biological composite materials derived from natural origin.
In recent years, technological advances and medical innovations has revolutionized the implantable biomaterials so as to include them in brain simulators and in artificial heart surgery resulting in growing adoption of the implantable biomaterials in medical procedures. Due to increasing geriatric population and the rising presence of chronic disease, the number of people who can benefit from implantable biomaterials continues to grow which is expected to the primary factor fueling the growth of implantable biomaterial market over the globe. Implantable biomaterials are a lifesaving and health improving option for many patients so implantable biomaterial have been paid more attention in the past few years. According to a report of (IASP) International study of aesthetic and cosmetic procedure there has been increase in implantable surgeries in Brazil by 12.2 % in 2017 this increasing demand for implant surgery is another major factors which further drive the revenue generation in implantable biomaterials market. Favorable reimbursements for implantable biomaterials is another the factor driving the implantable biomaterials global market. However, most of the implantable biomaterials trigger acute or chronic inflammatory responses in the body. These reactions can totally black a biomaterial and even lead to huge disasters or personal misfortunes for the patient this factor is restraining the growth of implantable biomaterial market.
The global Implantable Biomaterials market is segmented on basis of material type, application type, end user and geographic region:
On the basis of material type, polymers segment are estimated to grow with a fastest growth rate in the forecast period due to its growing application in implant surgery its unique properties like durability, tensile strength and flexibility makes it more preferable in medical implant procedure. Polymers are being used in a variety of implants such as orthopedic fixation devices, (PTCA) catheters, heart valves, intraocular lenses, contact lenses, and for building rigid bases for dental prosthesis and dentures. On the basis of application, the orthopedic applications generates major share in the global implantable biomaterials market due to increasing number of hip and knee replacement performed across all geographies and increasing usage in sports medicine. Whereas, among end users hospitals and ambulatory surgical centers is anticipated to register highest growth rate over the forecast period
Based on geography, global implantable biomaterials market is segmented into six key regions viz. North America, Latin America, Europe, Asia Pacific Excluding China, China and Middle East & Africa. North America, specifically U.S. registered for the largest revenue shares in global Implantable Biomaterial market followed by Europe and Asia-Pacific. Increasingly, implantable biomaterials manufacturers are finding stiff competition in flourished markets in developed nations which have compelled them to focus on the underserved emerging markets. This approach will drive the implantable biomaterials market in the Asia-Pacific and Latin American countries in the coming years.
Some of the key players involved in global Implantable Biomaterial market are Invibio, Inc., Biomet, Inc., Celanese Corporation, AdvanSource Biomaterials Corporation, Collagen Matrix, Inc., Orthofix Holdings, Inc., Ceradyne, Inc., DuPont, Zimmer Biomet Holdings, Evonik Industries AG, Royal DSM and Corbion Purac.
The report covers exhaustive analysis on:
Regional analysis includes